论文部分内容阅读
目的:为有效治疗急性期脑梗死患者,临床观察氯吡格雷与依达拉奉联合的治疗效果。方法:选取我院2014.8~2015.8期间96例急性期脑梗患者,按病床单双号分为联合组48例、单一组48例。单一组采用依达拉奉,联合组在单一组治疗基础上加用氯吡格雷,观察两组治疗效果。结果:联合组临床效率为95.8%,单一组为81.3%,单一组较联合组疗效差,P<0.05;治疗前两组凝血功能指标比较差别无意义,P>0.05;治疗后联合组较单一组凝血功能指标改善好,P<0.05。结论:临床对于急性脑梗患者治疗,采用依达拉奉与氯吡格雷联合用药,患者恢复快、疗效好、凝血功能恢复好。
Objective: To effectively treat patients with acute cerebral infarction, clinical observation of clopidogrel and edaravone combined treatment. Methods: A total of 96 acute cerebral infarction patients from 2014.8 to 2015.8 in our hospital were selected and divided into 48 cases in the combination group and 48 cases in the single group according to the single and double bed number. A single group with edaravone, the combined group in a single group plus clopidogrel treatment, the two groups were observed. Results: The clinical efficacy was 95.8% in the combined group and 81.3% in the single group. The curative effect in the single group was poorer than that in the combined group (P <0.05). There was no significant difference in the coagulation function between the two groups before treatment (P> 0.05) Group coagulation improved significantly, P <0.05. Conclusion: Clinical treatment of patients with acute cerebral infarction, the use of edaravone and clopidogrel combination therapy, patients with fast recovery, good efficacy, good coagulation recovery.